Articles

Serbia’s Institute of Virology, Vaccines, and Sera “Torlak” is a trusted, recognized vaccine producer in Serbia. As part of the influenza vaccine development project, it conducted its first complex vaccine clinical trial in humans, which helps position Torlak as an essential vaccine producer for the Balkan region.

What's it like to volunteer for for a clinical trial? One participant in Vietnam reflects on the opportunity to contribute to the country's influenza defenses.

Dr. Le Van Be, director of the Institute of Vaccines and Medical Biologicals, believes in the power of vaccines. And he is committed to seeing locally made influenza vaccine become a reality.

An incurable disease sometimes referred to as “brain fever” once ravaged communities across Asia. But thanks to PATH and our partners, Japanese encephalitis is no longer the threat it once was. A 20-year effort turned a little-known vaccine from China into an internationally approved immunization tool. The vaccine has now reached more than 300 million children—a turning point in the battle to protect people from this dreaded disease.